By
Drug Target Review2025-02-27T09:00:18
Researchers have identified a small gene, SCN10a-short, that could enable gene therapy to treat malignant cardiac arrhythmias. This discovery offers the potential for a one-time treatment, reducing the reliance on lifelong medication and invasive procedures.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T09:00:00Z
2023-11-20T13:43:43
Sponsored by Merck
2026-06-02T15:00:00
Sponsored by Danaher Life Sciences
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-05-10T11:18:16
Sponsored by Revvity
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-03-30T09:15:30
Sponsored by Halo Labs
Site powered by Webvision Cloud